Experience
Wyeth
Lupin Ltd and Lupin Pharmaceuticals, Inc.
Represented Wyeth in multiple separate Hatch-Waxman litigations concerning Effexor XR®, a multibillion dollar antidepressant; the cases were resolved through confidential settlement at various stages of litigation, including in the midst of trial.
Wyeth v. Lupin Ltd and Lupin Pharmaceuticals, Inc., 1:07-cv-00632, D. Del., Judges Quarles, Gauvey
InnoPharma Licensing, Inc.; Lupin Ltd.; and Metrics, Inc. v. Senju Pharmaceuticals Co.
Bausch Health Companies
Lupin Pharmaceuticals, Inc. v. Pozen Inc.
Horizon Pharma USA, Inc.; Pozen Inc.
Senju Pharmaceutical Co.; Bausch + Lomb v. Lupin Ltd.
Senju Pharmaceutical Co.; Bausch + Lomb
Israel Bio-Engineering Project v. Amgen Inc., et al.
Amgen Inc., Immunex Corp.
Housey Pharmaceuticals, Inc. v. Otsuka Pharmaceutical Co. Ltd.
Otsuka Pharmaceutical Co. Ltd.
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.